SignalDeck — Stock Watchlist & Trigger Monitor

DISCLAIMER: This is a quantitative framework for educational and informational purposes only. It is not financial advice. Always do your own research and consult a licensed financial advisor before making investment decisions.

3

Tickers Tracked

7

Buy Signals

2

Hold Signals

0

Active Triggers

1

Approaching

Watchlist

TickerThe stock's exchange ticker symbol, company name, and sector classification.	PriceLatest closing price in the stock's local currency (USD or CAD). Updated at each scheduled check.	ChangeYear-to-date percentage change from the Jan 1 opening price. Green = gain, red = loss.	QualBusiness Quality (0-100) Scores the underlying business: competitive moat (5 dimensions), ROIC, capital allocation, revenue growth, profitability, and balance sheet. Sector-specific metrics apply — e.g. resource quality for miners, member growth for fintech. Higher = stronger business.	ValValuation Attractiveness (0-100) Is the price right? Uses reverse-DCF implied growth, FCF yield, analyst target consensus, historical valuation decile, and sector-appropriate multiples (P/NAV for miners, PEG for growth). Higher = more attractive price.	TimeEntry/Exit Timing (0-100) Multi-timeframe technical analysis across monthly, weekly, and daily charts. Includes risk-reward ratio, relative strength vs sector ETFs, and momentum indicators (RSI, MACD, Bollinger). Higher = better entry timing.	DrvUnderlying Driver (0-100) Scores the dominant macro force affecting this stock — e.g. commodity prices for miners, interest rates for banks, AI capex for tech. Captures tailwinds and headwinds that the three pillars don't directly measure. Higher = stronger tailwind.	ShortShort-term Signal (1-3 months) BUY / HOLD / SELL recommendation for the next 1-3 months. Weights Timing and Driver most heavily, with less emphasis on Quality. Best for swing trades and tactical entries.	MedMedium-term Signal (6-12 months) BUY / HOLD / SELL recommendation for a 6-12 month horizon. Balanced weighting across all three pillars. Best for position trades and catalyst-driven plays.	LongLong-term Signal (3-5 years) BUY / HOLD / SELL recommendation for a multi-year hold. Weights Business Quality and Valuation most heavily, with minimal Timing weight. Best for core portfolio positions.	CatalystNext Catalyst The nearest upcoming event that could materially move the stock — earnings releases, feasibility studies, regulatory decisions, product launches, etc.	ReportClick to open the full interactive v4 signal report with detailed scoring, charts, scenario analysis, and calibration data.
NASDAQ:ABCL AbCellera Biologics CA00288U1066 Healthcare/Biotech	$3.41	-21.6% YTD -0.58% today	67	78	55	70	HOLD	BUY	BUY	Phase 2 readout Q3 2026	View→ Archive
Entry Rules Insider Floor Price within $3.27–$3.42 insider buy zone • CFO Booth +42.6k sh, Thermopylae +215k sh clustering at current level $3.41 — INSIDE zone ✓ — informed-buyer floor active Active now — insiders are accumulating at the current price; supports the long-term BUY thesis MET Technical Reclaim 200-SMA $4.13 on 1.5x volume • RSI 45-65 • RS vs XBI improving $3.41 < 200-SMA $4.13 ✗ — gap 21.1%; 6mo RS vs XBI −65.1 pts ~6-12 weeks — needs sector tailwind to flow through; would lift Short signal from HOLD to BUY NOT MET Catalyst Phase 2 ABCL635 readout in window • partnership announcement • Phase 1 ABCL575 update Phase 2 readout Q3 2026 — ~5 months away Q3 2026 — binary event; ~30% phase-2 base rate POS, but de-risking sentiment trades in advance PENDING Exit Rules Stop-Loss Close below $2.00 (just under 52-week low $1.94) for 2 consecutive days $3.41 — $1.41 buffer (41.3%) Unlikely — price would need to break the prior cycle low; only on dilution + Phase 2 fail CLEAR Thesis Break ABCL635 Phase 2 fails • Major dilution >15% from $45.5M shelf • Cash runway drops below 24 months Monitoring — cash 5.8 yrs, no shelf draw yet Unlikely near-term — runway is the strongest in the watchlist; binary risk concentrated in Q3 2026 CLEAR Profit Target Price ≥ $9.17 (analyst mean) AND Phase 2 positive AND RSI > 70 $3.41 — needs +169% 12-18 months — requires Phase 2 success + sector re-rate; path: $5.50 base → $9.17 mean → $12 high CLEAR Key Levels: Stop $2.00 Insider Buy $3.27–$3.42 200-SMA $4.13 Leerink Tgt $4.00 Base Case $5.50 Analyst Mean $9.17 Analyst High $12.00
NYSE:UNH UnitedHealth Group Healthcare	$306.88	-49.4% YTD -0.15% today	46	65	41	60	HOLD	HOLD	HOLD	Earnings Apr 21	View→ Archive
Entry Rules Fundamental MCR ≤ 87% in Q1 • EPS guidance ≥ $17.75 • No DOJ escalation Earnings Apr 21 — 13 days away. Consensus Q1 EPS $6.59 Depends on Apr 21 earnings — MCR improvement plausible given 2.48% MA rate increase but may not show in Q1 results PENDING Technical Close above $322 (200-SMA) on 1.5x volume • RSI 40-65 • MACD cross Price $306.88 < 200-SMA $322 ✗ — gap 4.9%; above 50-SMA $292.9 ✓ ~4-8 weeks — needs 5% rally + earnings support to reclaim 200-SMA; death cross still in effect APPROACHING Value Price $265-275 (March support) • FCF yield > 7% $306.88 — needs -12% decline to zone Only on earnings miss or selloff — would require significant negative catalyst PENDING Exit Rules Stop-Loss Close below $234.67 (52-week low) for 2 consecutive days $306.88 — $72.21 buffer (23.5%) Unlikely next 4-6 weeks — price 24% above level; only on DOJ escalation + earnings miss CLEAR Thesis Break FY2026 guidance < $15 adj EPS • MCR > 91% • DOJ charges filed Monitoring — earnings Apr 21 Unlikely — barring worst-case scenario (~15% probability) CLEAR Profit Target Price ≥ $380 (analyst median) AND RSI > 70 $306.88 — needs +23.8% 6-12 months — requires margin recovery + DOJ resolution; path: $340 post-Q1 → $380 by Q3 CLEAR Key Levels: Stop $234.67 Support $266 Support $281 50-SMA $292.9 200-SMA $322 Fair Value $380 Analyst $364
NASDAQ:SOFI SoFi Technologies US83406F1021 Fintech	$16.27	-39.0% YTD +2.34% today	72	70	45	65	HOLD	BUY	BUY	Earnings Apr 29	View→ Archive
Entry Rules Fundamental Price < $18 • RSI > 30 • No earnings within 7 days $16.27 < $18 ✓ RSI ~37 > 30 ✓ Earnings 23d away ✓ Currently met — price recovered +2.34% today (first day post-Good Friday) MET Technical Close above SMA20 on 1.5x volume • MACD hist positive 3+ days Price $16.27 < SMA20 ~$16.77 ✗ — gap 3.1%; MACD histogram day 2/3 positive; RSI 37 > 35 ✓ ~1-2 weeks — SMA20 gap narrowed to 3.1% (was 7%); MACD on day 2 of 3 needed; one more up day + volume spike completes trigger APPROACHING Catalyst Post-earnings move > +5% on 2x volume • Guidance raised Earnings Apr 29 — 23 days away Earnings Apr 29 — tariff environment adds uncertainty; consensus expects Q1 rev ~$1.04B; guidance raise 60% likely if macro stabilizes PENDING Exit Rules Stop-Loss Close below $14.50 for 2 consecutive days $16.27 — $1.77 buffer (10.9%) Moderate concern — Apr 2 intraday low $14.93 was only $0.43 above stop; tariff volatility elevated (VIX 23.87); watch closely on any renewed selloff CLEAR Thesis Break Q1 revenue < $1.0B OR FY guidance < $4.4B Earnings Apr 29 — monitoring Unlikely — consensus Q1 rev $1.04B; only triggers on major miss (~20% probability) CLEAR Profit Target Price ≥ $21 AND RSI > 70 $16.27 — needs +29.1% 6-12 months — requires 2-3 quarterly beats; path: $18 post-Q1 (Apr 29) → $21-22 post-Q3 CLEAR Key Levels: Stop $14.50 Support $14.93 Support $16.48 SMA20 ~$16.77 Fair Value $18–21 Analyst $25.50
NASDAQ:DLO DLocal Limited KYG290181018 EM Payments	$12.75	-10.6% YTD -0.86% today	85	78	55	78	HOLD	STR BUY	STR BUY	Earnings May 13	View→ Archive
Entry Rules Fundamental Price < $14 • Forward P/E < 15x • NRR > 140% $12.75 < $14 ✓ Fwd P/E 13.7x ✓ NRR ~150% ✓ Currently met — all three conditions satisfied; window may close if price rallies post-earnings May 14 MET Technical Hold $12.19 support • RSI < 40 • Green candle on 1.5x volume $12.75 above $12.19 ✓ RSI ~52 > 40 ✗ No volume spike (below avg) 4-6 weeks — RSI needs to pull back from ~52 to below 40 for a clean setup; await a genuine pullback to $12.19 support with RSI confirmation, then volume catalyst NOT MET Catalyst Q1 2026 earnings beat • TPV growth > 55% • NRR > 150% Earnings May 14 — pending Earnings May 14 — TPV growth accelerating (42% → 51% last 2Q); NRR 162% already > 150%; beat probability ~70% PENDING Exit Rules Stop-Loss Close below $11.15 for 2 consecutive days $12.75 — $1.60 buffer (12.6%) Low probability next 4-6 weeks — Apr 2 intraday low $11.99 came within $0.84 of stop; close held above $12.19; watch for tariff-driven EM risk-off retest CLEAR Thesis Break NRR < 120% • GM < 30% • EM regulatory crackdown NRR 162%, GM 34% — clear Unlikely — NRR 162% (42pts above threshold); GM stable 33-35% range; no pending EM regulation CLEAR Profit Target Price ≥ $21 AND RSI > 70 $12.75 — needs +64.7% 6-9 months — fair value $16.83; post-earnings re-rate to $16-17 likely; $21 requires 2-3 quarterly beats CLEAR Key Levels: Stop $11.15 Support $12.19 Support $11.37 Fair Value $16.83 Analyst $17.25 Target $21.00
TSX:MNO Meridian Mining UK Societas GB00BR3SVZ18 ⛏ Gold-Cu Developer	C$1.72	+312.77% 1yr 14% below 52w high	80	89	83	88	WAIT	STR BUY	STR BUY	US CPI + CA Jobs Apr 10	View→ Archive
Entry Rules Fundamental Price < C$2.20 • Cash > C$60M • No adverse permitting news C$1.72 < C$2.20 ✓ Cash C$100M+ ✓ PL approved ✓ Currently met — all three conditions satisfied; C$1.72 is within the ideal entry zone C$1.70-1.80 MET Technical (Optimal) Pullback to C$1.70-1.80 • RSI < 55 • Hold above C$1.58 support C$1.72 within C$1.70-1.80 zone ✓ • RSI ~62 ✓ • C$1.58 support intact ✓ Currently met — price pulled back into ideal entry zone; R/R 2.66:1 to analyst consensus at current price MET Short-term Event Wait for US CPI print & CA jobs report before short-term add Apr 10 — US CPI + CA jobs concurrent; gold/copper sensitivity elevated 0–1 week — v5 short-term signal is WAIT FOR EVENT; hot CPI = gold softens, jobs beat = CAD strength reduces TSX miner tailwind PENDING Catalyst IL submission confirmed OR long-lead items placed IL target H1 2026 — imminent; long-lead orders by end Q1 2026 Near-term — both catalysts targeted within weeks to months; buy on confirmation of either — gap up likely PENDING Exit Rules Stop-Loss Close below C$1.25 for 2 consecutive days C$1.72 — C$0.47 buffer (27.3%) Low probability — C$1.58 institutional bought deal support provides strong floor; stop at C$1.25 is well protected by multiple support levels CLEAR Thesis Break IL rejected/delayed >6mo • Cash < C$30M • Copper < $3.00/lb 90d IL on track • Cash C$100M+ • Copper $5.88/lb • Gold $4,670 ATH Unlikely — CONSEMA unanimous PL approval indicates positive permitting trajectory; cash runway 3+ years; copper far above floor CLEAR Profit Target Price ≥ C$3.50 AND RSI > 75 C$1.72 — needs +103.5% 6-18 months — analyst high target C$3.50; achievable on IL + DFS delivery at current gold prices; trim at C$3.50, let rest run with trailing stop CLEAR Key Levels: Stop C$1.25 Bought Deal C$1.58 Ideal Entry C$1.70-1.80 Resistance C$2.00 Analyst C$2.97 PFS NAV C$3.26 Target C$3.50

How the v4 Framework Works

Business Quality (0-100)

Competitive moat (5 dimensions), ROIC & capital allocation, revenue, profitability, balance sheet. Sector-specific: resource quality for miners, member growth for fintech.

Valuation Attractiveness (0-100)

Reverse-DCF implied growth, FCF yield, analyst consensus, historical decile, sector multiples (P/NAV, PEG, EV/EBITDA).

Entry/Exit Timing (0-100)

Multi-timeframe technicals, risk-reward, relative strength, dynamic macro weighting, sentiment/catalyst layers. Hard gates & Do-Not-Buy triggers.

Short-term weights Timing. Long-term weights Quality. Underlying Driver captures the dominant macro force. Triggers monitored 2x daily at 12:30 PM and 5:00 PM ET.